loading...| Preferred Name |
enalaprilat |
|
| Synonyms |
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline enalaprilat dihydrate enalaprilat (anhydrous) |
|
| Definitions |
This is any condition in which the main influencing factor is enalaprilat, the active metabolite of the orally available pro-drug enalapril. Used in the treatment of hypertension, heart failure, and nephropathies, enalapril is an ACE inhibitor that prevents Angiotensin Converting Enzyme (ACE) from transforming angiotensin I into angiotensin II. Enalaprilat is enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001346 |
|
| created_by |
slaulederkind |
|
| creation_date |
2024-04-12T12:43:11Z |
|
| database_cross_reference |
CHEBI:59877 CHEBI:4786 |
|
| definition |
This is any condition in which the main influencing factor is enalaprilat, the active metabolite of the orally available pro-drug enalapril. Used in the treatment of hypertension, heart failure, and nephropathies, enalapril is an ACE inhibitor that prevents Angiotensin Converting Enzyme (ACE) from transforming angiotensin I into angiotensin II. Enalaprilat is enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. |
|
| has_exact_synonym |
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| has_related_synonym |
enalaprilat dihydrate enalaprilat (anhydrous) |
|
| id |
XCO:0001346 |
|
| label |
enalaprilat |
|
| notation |
XCO:0001346 |
|
| prefLabel |
enalaprilat |
|
| treeView | ||
| subClassOf |